Liver Disease
Learn More About Liver Disease Clinical Trials!
New treatments for patients with liver disease are being developed everyday! Take a look at some recent advancements in liver disease treatment:
“Some new agents for the treatment of cholestatic liver diseases have progressed through to approval recently, while others are now in various stages of clinical development…”
“Arrowhead expects to file a clinical trial application in the first quarter of 2018 to begin first-in-human studies of ARO-AAT….”
““The findings from this Phase 2 study of A4250 on various efficacy measures, and the safety and tolerability profile shown, are promising,” said Dr. Sturm, head of pediatric gastroenterology-hepatology, liver and intestinal transplantation at Children’s Hospital, University of Tuebingen in Germany.”
“Extracellular Vesicles are explored as biomarkers of disease and could also represent therapeutic targets and vehicles for treatment delivery.”
“Patients with fatty liver disease reduced their BMI and alanine aminotransferase levels following a regimented health education, nutrition and exercise program, according to study results presented at Emerging Trends in Non-Alcoholic Fatty Liver Disease.”
GET IN TOUCH
SUBMIT RFI/RFP
NEWS AND BLOG